Hims & Hers (HIMS) just gave us a textbook Ichimoku breakout and is holding strong above the cloud after a healthy pullback.
Technical Breakdown:
Price above Kumo Cloud: Bullish structure intact.
Support held at $54.62 – key base above cloud and Tenkan-sen.
MACD is curling back after a corrective wave, showing early signs of momentum returning.
Risk/Reward: 8.59 – Extremely favorable.
Target: $93.58 (60.22% upside)
Stop: $51.78 (7.01% downside)
Rationale:
HIMS continues to ride bullish sentiment in the healthcare and telemedicine sectors. This chart has a clean continuation setup with institutional buy zones likely around $54-$55. Risk is tightly controlled, and upside potential is significant.
Technical Breakdown:
Price above Kumo Cloud: Bullish structure intact.
Support held at $54.62 – key base above cloud and Tenkan-sen.
MACD is curling back after a corrective wave, showing early signs of momentum returning.
Risk/Reward: 8.59 – Extremely favorable.
Target: $93.58 (60.22% upside)
Stop: $51.78 (7.01% downside)
Rationale:
HIMS continues to ride bullish sentiment in the healthcare and telemedicine sectors. This chart has a clean continuation setup with institutional buy zones likely around $54-$55. Risk is tightly controlled, and upside potential is significant.
Trade active
Trade closed: stop reached
Stop reached. Trade Closed. 7% loss. Still probably a long term play. 
If you found my trades helpful, please consider sending a tip in BTC to: bc1qr35mrh82hykpy9v6znpsyuew85x84ezjyrrf6m
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
If you found my trades helpful, please consider sending a tip in BTC to: bc1qr35mrh82hykpy9v6znpsyuew85x84ezjyrrf6m
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.